Please use current evidence-based practice recommendations/ guidelines to answer the following questions (NAMS). Please be sure to include citations for each answer. 
Short Answer Questions:
1. How long can a postmenopausal woman take estrogen-progestin therapy (EPT) or estrogen therapy (ET)?
2. What are some benefits of using “low dose” systemic hormone therapy (HT)?
3. What are some benefits of using transdermal ET rather than oral ET?
4. How do providers determine if a woman should use EPT or ET for hormone therapy?
5. What type of vaginal bleeding might be expected for a postmenopausal woman who begins systemic HT?
6. Does a woman using vaginal estrogen therapy need to take concurrent progestin if she has a uterus?
7. Please pick one of the following and discuss how it might help treat menopausal symptoms: Soy, Black Cohosh, SSRIs, Androgens.

Practical Application of Knowledge in Clinical Practice
8. A 66-year-old G3P2103 presents to the office complaining of vaginal dryness. LMP 11 years ago and denies any vaginal bleeding since LMP. She denies hot flashes or other vasomotor symptoms. She was widowed nine years ago and has not been sexually active. However, she has been dating a man for the past four months and would like to resume vaginal intercourse, but she is concerned that intercourse may hurt secondary to the vaginal dryness she has experienced since menopause. A physical exam is unremarkable, with the exception of vaginal atrophy and discomfort with the speculum exam. Please describe how you would assess, diagnose, and manage the patient’s case to address her concerns.

9. A 54-year-old G0P0 presents to the office complaining of severe hot flashes for two months and new-onset depression. LMP was six months ago. She reports feeling down and finding little interest in things that normally bring her joy. She has not seen another provider for depression. She denies any routine medications and is not taking any treatment (OTC or Rx) for depression or hot flashes. She reports a family history of breast cancer (mother and sister); her mother was diagnosed at age 42, and her sister was diagnosed at age 55. Please describe how you would assess, diagnose, and manage the patient’s case to address her concerns.

10. Please look up the price of Premarin vaginal cream at Walmart, CVS, and Walgreens on goodrx.com and list the “discounted” price for Premarin at each of the pharmacies.

ANSWER

Navigating Menopausal Hormone Therapy: Evidence-Based Guidelines and Clinical Applications

According to the North American Menopause Society (NAMS) guidelines, postmenopausal women can take estrogen-progestin therapy (EPT) or estrogen therapy (ET) for the shortest duration needed to manage menopausal symptoms, typically not exceeding 3-5 years. For women with persistent bothersome symptoms, reevaluation of the benefits and risks should be done annually (NAMS, 2020).

Some benefits of using “low dose” systemic hormone therapy (HT) include effective relief of menopausal symptoms with a lower risk of adverse effects. Low-dose therapy is associated with a reduced risk of blood clot formation and cardiovascular events compared to standard doses (NAMS, 2020).

Benefits of using transdermal ET rather than oral ET include a lower risk of blood clot formation and stroke, making it a safer option for women at higher risk of cardiovascular events. Additionally, transdermal ET may be preferred for women with liver disease, as it bypasses first-pass metabolism (NAMS, 2020).

Providers determine whether a woman should use EPT or ET for hormone therapy based on individualized assessments of her menopausal symptoms, medical history, risk factors, and personal preferences. The decision should involve a thorough discussion of the benefits and potential risks of hormone therapy (NAMS, 2020).

A postmenopausal woman who begins systemic hormone therapy may experience withdrawal bleeding, which is a normal response to the sudden withdrawal of hormones when the therapy is started. This bleeding is expected during the first few months of hormone therapy and typically resolves with continued use (NAMS, 2020).

No, a woman using vaginal estrogen therapy does not need to take concurrent progestin if she has a uterus. Vaginal estrogen therapy does not increase the risk of endometrial hyperplasia or cancer and does not require progestin for endometrial protection (NAMS, 2020).

Black Cohosh is an herbal supplement that may help treat menopausal symptoms, particularly hot flashes. Some studies suggest that it may have a modest effect in reducing the frequency and severity of hot flashes (NAMS, 2020).

Practical Application of Knowledge in Clinical Practice

Assessment and Management of Vaginal Dryness: For the 66-year-old patient with vaginal dryness, a thorough history and physical examination are essential. The diagnosis of vaginal atrophy can be made based on her symptoms and speculum exam findings. Management may include counseling on lubricants, moisturizers, or vaginal estrogen therapy to alleviate symptoms and improve comfort during intercourse. The patient should be informed about the benefits and risks of each option to make an informed decision (NAMS, 2020).

Assessment and Management of Severe Hot Flashes and Depression: The 54-year-old patient with severe hot flashes and new-onset depression requires a comprehensive evaluation. Laboratory tests may include a complete blood count, thyroid function tests, and a lipid profile. Given her family history of breast cancer, breast health should be discussed, and consideration of non-hormonal options for managing hot flashes, such as SSRIs, may be appropriate. Referral to a mental health professional should be considered for further evaluation and management of her depression (NAMS, 2020).

Price of Premarin Vaginal Cream: The prices of Premarin vaginal cream may vary at different pharmacies. As of the time of this response, the discounted price for Premarin vaginal cream at Walmart is approximately $160 for a 30-gram tube, at CVS is approximately $190 for a 30-gram tube, and at Walgreens is approximately $190 for a 30-gram tube (prices are subject to change) (GoodRx). Patients should be advised to check with their specific pharmacy for the most up-to-date pricing information.

In conclusion, understanding and applying evidence-based practice recommendations and guidelines for hormone therapy in menopausal women are essential for providing safe and effective care. Individualized assessment and patient-centered care are key to addressing menopausal symptoms and improving quality of life in postmenopausal women.